Publicaciones en colaboración con investigadores/as de University of Oxford (12)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2023

  1. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  2. Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury

    JCI Insight, Vol. 8, Núm. 2

  3. Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma

    Cell Reports Medicine, Vol. 4, Núm. 4

2022

  1. Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19

    Chest, Vol. 162, Núm. 5, pp. 1006-1016

2016

  1. T-and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates

    Gene Therapy, Vol. 23, Núm. 10, pp. 753-759

2015

  1. A core of kinase-regulated interactomes defines the neoplastic MDSC lineage

    Oncotarget, Vol. 6, Núm. 29, pp. 27160-27175

2013

  1. Combining virotherapy and angiotherapy for the treatment of breast cancer

    Cancer Gene Therapy, Vol. 20, Núm. 8, pp. 461-468

  2. Identification of Targets of CD8+ T Cell Responses to Malaria Liver Stages by Genome-wide Epitope Profiling

    PLoS Pathogens, Vol. 9, Núm. 5

2011

  1. Research reporting standards for radioembolization of hepatic malignancies

    Journal of Vascular and Interventional Radiology, Vol. 22, Núm. 3, pp. 265-278

2008

  1. Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus

    Human Gene Therapy, Vol. 19, Núm. 9, pp. 873-886